GianosESchoenthalerAGuoY, et al.
Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial. Am Heart J2018;
199: 37–43.
2.
GianosESchoenthalerAMushailovM, et al.
Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial. Am Heart J2015;
170: 430–437; e439.
3.
MaronDJHochmanJSO’BrienSM, et al.
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J2018;
201: 124–135.
4.
MaronDJHarringtonRAHochmanJS.Planning and Conducting the ISCHEMIA Trial. Circulation2018;
138: 1384–1386.
5.
KosiborodMCavenderMAFuAZ, et al.
Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors). Circulation2017;
136: 249–259.
6.
LillieEOPatayBDiamantJ, et al.
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Per Med2011;
8: 161–173.
7.
ShafferJAKronishIMFalzonL, et al.
N-of-1 Randomized intervention trials in health psychology: a systematic review and methodology critique. Ann Behav Med2018;
52: 731–742.
8.
KronishIMCheungYKShimboD, et al.
Increasing the Precision of Hypertension Treatment Through Personalized Trials: a pilot study. J Gen Intern Med2019;
34: 839–845.
9.
FrederixICaianiEGDendalePal.ESC e-Cardiology Working Group position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol2019;
26: 1166–1177.
